Overview

Study to Evaluate the Efficacy and Safety of Combination Aliskiren/Amlodipine in Patients With Hypertension Not Adequately Responding to Amlodipine Alone

Status:
Completed

Trial end date:
2009-06-01

Target enrollment:

Participant gender:

Summary

This study will assess the safety and efficacy of combination aliskiren/amlodipine in patients with hypertension not adequately controlled with amlodipine alone.

Phase:

Phase 3

Details

Lead Sponsor:

Novartis

Treatments:

Amlodipine